The metabolic reprogramming and vulnerability of SF3B1 mutations

Area of Science:

• Molecular Biology
• Cell Metabolism
• Cancer Biology

Background:

• Mutations in the splicing factor 3b subunit 1 (SF3B1) gene lead to aberrant RNA splicing.
• The precise downstream effects of SF3B1 mutations on cellular processes remain largely unknown.
• Altered cellular metabolism is a hallmark of many cancers, often driven by genetic mutations.

Purpose of the Study:

• To investigate the downstream consequences of SF3B1 mutations on cellular functions.
• To explore the impact of SF3B1-induced missplicing on cellular energy metabolism.
• To identify potential therapeutic vulnerabilities associated with SF3B1 mutations.

Main Methods:

• Utilized isogenic human cell models with and without SF3B1 mutations.
• Performed comprehensive analysis of cellular energy metabolism pathways.
• Assessed cell viability and metabolic responses under nutrient deprivation conditions.

Main Results:

• SF3B1 mutations induce significant reprogramming of cellular energy metabolism.
• Cells with SF3B1 mutations exhibit a heightened dependency on serine for survival.
• Deprivation of the nonessential amino acid serine selectively impairs SF3B1-mutant cells.

Conclusions:

• SF3B1 mutations trigger a metabolic shift that creates a specific vulnerability.
• Targeting serine metabolism represents a promising therapeutic strategy for SF3B1-mutant conditions.
• Understanding SF3B1-driven metabolic alterations is crucial for developing novel cancer therapies.